Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • New for You
  • Covid-19
  • Video
  • Podcasts

Search Results for regeneron

Vaccine Delays in Europe Lead to German Direct Purchase of $486m of Lilly & Regeneron Monoclonal Antibody Products Despite No Formal Approval

As frustration mounts in places such as Germany with what is perceived as a slow and inefficient vaccine rollout, calls […]

Vaccine Delays in Europe Lead to German Direct Purchase of $486m of Lilly & Regeneron Monoclonal Antibody Products Despite No Formal Approval
21 mins ago
Share
0

HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19

The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Regeneron’s investigational monoclonal antibody […]

HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
2 months ago
Share
1

U.S. FDA Authorizes Regeneron’s REGN-COV2 Monoclonal Antibody for Emergency Use Authorization Targeting Select COVID-19 Patients

The monoclonal antibody cocktail developed by Regeneron and made well-known by POTUS during his stay at Walter Reed Medical Center […]

U.S. FDA Authorizes Regeneron’s REGN-COV2 Monoclonal Antibody for Emergency Use Authorization Targeting Select COVID-19 Patients
2 months ago
Share
0

IDMC Observes Some Safety Signals in Regeneron’s Study of REGN-COV2 in Hospitalized Patients: Recommendations Made to Modify

Regeneron’s monoclonal antibody investigational product known as REGN-COV2 has been touted by trial site’s all over the United States, almost […]

IDMC Observes Some Safety Signals in Regeneron’s Study of REGN-COV2 in Hospitalized Patients Recommendations Made to Modify
3 months ago
Share
2

Regeneron’s COVID-19 Outpatient Trial Shows Positive, Prospective Results

Regeneron Pharmaceuticals, Inc. announced October 28th, 2020 positive, prospective results from an ongoing Phase 2/3 seamless trial in the COVID-19 […]

Regeneron's COVID-19 Outpatient Trial Shows Positive, Prospective Results
3 months ago
Share
2

Regeneron and Sanofi Announce Dupixent Effective in Phase 3 Pediatric Asthma Trial

Regeneron and Sanofi announced positive results from the phase 3 LIBERTY ASTHMA VOYAGE trial which evaluated Dupixent (dupilumab) in children aged […]

Regeneron and Sanofi Announce Dupixent Effective in Phase 3 Pediatric Asthma Trial
3 months ago
Share
0

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly

Regeneron reported that subsequent to the New York-based company’s discussions with regulatory authorities, they have submitted a request to the […]

Regeneron Submits Request for FDA EUA for REGN-COV2 in Head to Head Competition with Eli Lilly
4 months ago
Share
0

Patent Holder Sues Regeneron & Pfizer & BioNTech Over Use of Proprietary ‘mNeonGreen’ Tech for COVID-19

Much attention has gone to Regeneron and the monoclonal antibody cocktail known as REGN-CoV2, especially given the investigational drug was […]

Patent Holder Sues Regeneron & Pfizer & BioNTech Over Use of Proprietary ‘nNeonGreen’ Tech for COVID-19
4 months ago
Share
0

Trial Site Operation in San Antonio Reports Positive Momentum for Regeneron Monoclonal Antibody REGN-COV-2

TrialSite has reported that Lilly’s monoclonal antibody (LY-CoV555) evidenced promise at a trial site location in southern Texas and that […]

Trial Site Operation in San Antonio Reports Positive Momentum for Regeneron Monoclonal Antibody REGN-COV-2
4 months ago
Share
3

Oxford RECOVERY Trial Investigates Regeneron’s REGN-COV2: Will it Reduce Mortality, Hospital Stay & Need for Ventilation?

The prominent global RECOVERY (Randomized Evaluation of COVid-19 thERapY) is one of the world’s largest randomized clinical trials of potential […]

Oxford RECOVERY Trial Investigates Regeneron’s REGN-COV2 Will it Reduce Mortality, Hospital Stay & Need for Ventilation
4 months ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
    In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.